{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T12:01:50Z","timestamp":1783598510339,"version":"3.55.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T00:00:00Z","timestamp":1724716800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000738","name":"Department of Veterans Affairs","doi-asserted-by":"publisher","award":["I01CX000916"],"award-info":[{"award-number":["I01CX000916"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007059","name":"Northwestern University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007059","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["CA77816"],"award-info":[{"award-number":["CA77816"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["CA12192"],"award-info":[{"award-number":["CA12192"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001422","name":"American Society of Hematology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001422","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Neoplasia"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.bneo.2024.100037","type":"journal-article","created":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T06:06:32Z","timestamp":1724825192000},"page":"100037","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Targeting SLFN11-regulated pathways restores chemotherapy sensitivity in AML"],"prefix":"10.1016","volume":"1","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1246-0250","authenticated-orcid":false,"given":"Sara H.","family":"Small","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5912-3505","authenticated-orcid":false,"given":"Ricardo E.","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3180-2742","authenticated-orcid":false,"given":"Elspeth M.","family":"Beauchamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aneta H.","family":"Baran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2083-7460","authenticated-orcid":false,"given":"Stephen D.","family":"Willis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5691-689X","authenticated-orcid":false,"given":"Mariafausta","family":"Fischietti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9994-8579","authenticated-orcid":false,"given":"Michael","family":"Schieber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3510-9562","authenticated-orcid":false,"given":"Masha","family":"Kocherginsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6756-3620","authenticated-orcid":false,"given":"Diana","family":"Saleiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9740-7573","authenticated-orcid":false,"given":"Leonidas C.","family":"Platanias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bneo.2024.100037_bib1","series-title":"Acute myeloid leukemia - cancer stat facts: @NCICancerStats","year":"2021"},{"issue":"23","key":"10.1016\/j.bneo.2024.100037_bib2","first-page":"2813","article-title":"How I treat AML incorporating the updated classifications and guidelines","volume":"141","author":"El Chaer","year":"2023","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.bneo.2024.100037_bib3","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1089\/jir.2012.0133","article-title":"The Schlafen family of proteins and their regulation by interferons","volume":"33","author":"Mavrommatis","year":"2013","journal-title":"J\u00a0Interferon Cytokine Res"},{"issue":"1","key":"10.1016\/j.bneo.2024.100037_bib4","doi-asserted-by":"crossref","first-page":"94","DOI":"10.15252\/embr.201540964","article-title":"SLFN11 inhibits checkpoint maintenance and homologous recombination repair","volume":"17","author":"Mu","year":"2016","journal-title":"EMBO Rep"},{"issue":"3","key":"10.1016\/j.bneo.2024.100037_bib5","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.molcel.2018.01.012","article-title":"SLFN11 blocks stressed replication forks independently of ATR","volume":"69","author":"Murai","year":"2018","journal-title":"Mol Cell"},{"key":"10.1016\/j.bneo.2024.100037_bib6","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.pharmthera.2019.05.009","article-title":"Schlafen 11 (SLFN11), a restriction factor for replicative stress induced by DNA-targeting anti-cancer therapies","volume":"201","author":"Murai","year":"2019","journal-title":"Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.bneo.2024.100037_bib7","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1182\/blood.2019003782","article-title":"SLFN11 promotes stalled fork degradation that underlies the phenotype in Fanconi anemia cells","volume":"137","author":"Okamoto","year":"2021","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.bneo.2024.100037_bib8","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1158\/1535-7163.MCT-19-0926","article-title":"SLFN11 expression in advanced prostate cancer and response to platinum-based chemotherapy","volume":"19","author":"Conteduca","year":"2020","journal-title":"Mol Cancer Therapeut"},{"issue":"suppl 15","key":"10.1016\/j.bneo.2024.100037_bib9","doi-asserted-by":"crossref","first-page":"5065","DOI":"10.1200\/JCO.2019.37.15_suppl.5065","article-title":"SLFN11 expression (exp) in castration-resistant prostate cancer (CRPC) patients (pts) to predict response to platinum-based chemotherapy (PLT)","volume":"37","author":"Conteduca","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"issue":"37","key":"10.1016\/j.bneo.2024.100037_bib10","doi-asserted-by":"crossref","first-page":"15030","DOI":"10.1073\/pnas.1205943109","article-title":"Putative DNA\/RNA helicase Schlafen-11 (SLFN11) sensitizes cancer cells to DNA-damaging agents","volume":"109","author":"Zoppoli","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.bneo.2024.100037_bib11","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41416-021-01364-3","article-title":"Schlafen 11 predicts response to platinum-based chemotherapy in gastric cancers","volume":"125","author":"Takashima","year":"2021","journal-title":"Br J Cancer"},{"issue":"6","key":"10.1016\/j.bneo.2024.100037_bib14","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/s41587-020-0546-8","article-title":"Visualizing and interpreting cancer genomics data via the Xena platform","volume":"38","author":"Goldman","year":"2020","journal-title":"Nat Biotechnol"},{"issue":"3","key":"10.1016\/j.bneo.2024.100037_bib15","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2217\/epi-2017-0118","article-title":"MethSurv: a web tool to perform multivariable survival analysis using DNA methylation data","volume":"10","author":"Modhukur","year":"2018","journal-title":"Epigenomics"},{"issue":"9","key":"10.1016\/j.bneo.2024.100037_bib16","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1158\/2767-9764.CRC-22-0192","article-title":"SLFN11 negatively regulates non-canonical NFkB signaling to promote glioblastoma progression","volume":"2","author":"Fischietti","year":"2022","journal-title":"Cancer Res Commun"},{"issue":"557","key":"10.1016\/j.bneo.2024.100037_bib17","doi-asserted-by":"crossref","first-page":"eaap9921","DOI":"10.1126\/scisignal.aap9921","article-title":"IFN-\u03b3-inducible antiviral responses require ULK1-mediated activation of MLK3 and ERK5","volume":"11","author":"Saleiro","year":"2018","journal-title":"Sci Signal"},{"issue":"10","key":"10.1016\/j.bneo.2024.100037_bib18","doi-asserted-by":"crossref","first-page":"8062","DOI":"10.18632\/oncotarget.3509","article-title":"Dual targeting of acute myeloid leukemia progenitors by catalytic mTOR inhibition and blockade of the p110\u03b1 subunit of PI3 kinase","volume":"6","author":"Colamonici","year":"2015","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.bneo.2024.100037_bib19","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1158\/2767-9764.CRC-23-0010","article-title":"Targeting CHAF1B enhances IFN activity against myeloproliferative neoplasm cells","volume":"3","author":"Saleiro","year":"2023","journal-title":"Cancer Res Commun"},{"issue":"7","key":"10.1016\/j.bneo.2024.100037_bib20","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1182\/blood-2004-10-4003","article-title":"Differential regulation of the p70 S6 kinase pathway by interferon \u03b1 (IFN\u03b1) and imatinib mesylate (STI571) in chronic myelogenous leukemia cells","volume":"106","author":"Parmar","year":"2005","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.bneo.2024.100037_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0059848","article-title":"Two 4N cell-cycle arrests contribute to cisplatin-resistance","volume":"8","author":"Shen","year":"2013","journal-title":"PLoS One"},{"issue":"18","key":"10.1016\/j.bneo.2024.100037_bib22","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1038\/s41388-021-01761-1","article-title":"Schlafen 5 as a novel therapeutic target in pancreatic ductal adenocarcinoma","volume":"40","author":"Fischietti","year":"2021","journal-title":"Oncogene"},{"issue":"27","key":"10.1016\/j.bneo.2024.100037_bib23","doi-asserted-by":"crossref","first-page":"15938","DOI":"10.1074\/jbc.270.27.15938","article-title":"Interferon-\u03b1 engages the insulin receptor substrate-1 to associate with the phosphatidylinositol 3\u2019-kinase (\u2217)","volume":"270","author":"Uddin","year":"1995","journal-title":"J\u00a0Biol Chem"},{"issue":"6","key":"10.1016\/j.bneo.2024.100037_bib24","doi-asserted-by":"crossref","first-page":"849","DOI":"10.2217\/epi-2017-0019","article-title":"Methylation of SLFN11 is a marker of poor prognosis and cisplatin resistance in colorectal cancer","volume":"9","author":"He","year":"2017","journal-title":"Epigenomics"},{"issue":"24","key":"10.1016\/j.bneo.2024.100037_bib25","first-page":"6124","article-title":"Methylation of SLFN11 promotes gastric cancer growth and increases gastric cancer cell resistance to cisplatin","volume":"10","author":"Peng","year":"2019","journal-title":"J\u00a0Cancer"},{"issue":"1","key":"10.1016\/j.bneo.2024.100037_bib26","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s13148-022-01382-9","article-title":"Gene body methylation in cancer: molecular mechanisms and clinical applications","volume":"14","author":"Wang","year":"2022","journal-title":"Clin Epigenet"},{"issue":"7728","key":"10.1016\/j.bneo.2024.100037_bib27","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/s41586-018-0623-z","article-title":"Functional genomic landscape of acute myeloid leukaemia","volume":"562","author":"Tyner","year":"2018","journal-title":"Nature"},{"issue":"16","key":"10.1016\/j.bneo.2024.100037_bib28","doi-asserted-by":"crossref","first-page":"3864","DOI":"10.1182\/bloodadvances.2020001904","article-title":"Prognostic impact of the ELN2017 risk classification in patients with AML receiving allogeneic transplantation","volume":"4","author":"Grimm","year":"2020","journal-title":"Blood Adv"},{"issue":"4","key":"10.1016\/j.bneo.2024.100037_bib29","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","article-title":"Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel","volume":"129","author":"D\u00f6hner","year":"2017","journal-title":"Blood"},{"issue":"38","key":"10.1016\/j.bneo.2024.100037_bib30","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1200\/EDBK_199519","article-title":"Acute myeloid leukemia: the good, the bad, and the ugly","author":"Kuykendall","year":"2018","journal-title":"Ame Soc Clin Oncol Educ Bk"},{"issue":"5","key":"10.1016\/j.bneo.2024.100037_bib31","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1182\/blood.2019002697","article-title":"Impact of NPM1\/FLT3-ITD genotypes defined by the 2017 European LeukemiaNet in patients with acute myeloid leukemia","volume":"135","author":"D\u00f6hner","year":"2020","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.bneo.2024.100037_bib32","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1182\/blood.2022016867","article-title":"Diagnosis and management of AML in adults: 2022 ELN recommendations from an international expert panel on behalf of the ELN","volume":"140","author":"D\u00f6hner","year":"2022","journal-title":"Blood"},{"issue":"D1","key":"10.1016\/j.bneo.2024.100037_bib33","doi-asserted-by":"crossref","first-page":"D881","DOI":"10.1093\/nar\/gky1076","article-title":"BloodSpot: a database of healthy and malignant haematopoiesis updated with purified and single cell mRNA sequencing profiles","volume":"47","author":"Bagger","year":"2018","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"10.1016\/j.bneo.2024.100037_bib34","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1038\/sj.bjc.6604977","article-title":"Heterogeneity within AML with CEBPA mutations; only CEBPA double mutations, but not single CEBPA mutations are associated with favourable prognosis","volume":"100","author":"Pabst","year":"2009","journal-title":"Br J Cancer"},{"issue":"D1","key":"10.1016\/j.bneo.2024.100037_bib35","doi-asserted-by":"crossref","first-page":"D1083","DOI":"10.1093\/nar\/gkaa968","article-title":"CellMiner cross-database (CellMinerCDB) version 1.2: exploration of patient-derived cancer cell line pharmacogenomics","volume":"49","author":"Luna","year":"2021","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"10.1016\/j.bneo.2024.100037_bib36","doi-asserted-by":"crossref","first-page":"16","DOI":"10.6004\/jnccn.2021.0002","article-title":"NCCN Guidelines Insights: Acute Myeloid Leukemia, Version 2.2021","volume":"19","author":"Pollyea","year":"2021","journal-title":"J Natl Compr Canc Netw"},{"issue":"9","key":"10.1016\/j.bneo.2024.100037_bib37","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1001\/jama.2022.14578","article-title":"Diagnosis and treatment of myelodysplastic syndromes: a review","volume":"328","author":"Sekeres","year":"2022","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.bneo.2024.100037_bib38","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1073\/pnas.78.5.3235","article-title":"Lethality of human myeloblasts correlates with the incorporation of arabinofuranosylcytosine into DNA","volume":"78","author":"Major","year":"1981","journal-title":"Proc Natl Acad Sci USA"},{"issue":"19","key":"10.1016\/j.bneo.2024.100037_bib39","doi-asserted-by":"crossref","first-page":"8997","DOI":"10.1016\/S0021-9258(19)70512-2","article-title":"Correlation of cytotoxicity with incorporation of ara-C into DNA","volume":"255","author":"Kufe","year":"1980","journal-title":"J\u00a0Biol Chem"},{"issue":"12","key":"10.1016\/j.bneo.2024.100037_bib40","doi-asserted-by":"crossref","first-page":"4137","DOI":"10.1016\/j.celrep.2020.02.117","article-title":"Chromatin remodeling and immediate early gene activation by SLFN11 in response to replication stress","volume":"30","author":"Murai","year":"2020","journal-title":"Cell Rep"},{"key":"10.1016\/j.bneo.2024.100037_bib41","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.canlet.2020.09.016","article-title":"Reality CHEK: understanding the biology and clinical potential of CHK1","volume":"497","author":"Neizer-Ashun","year":"2021","journal-title":"Cancer Lett"},{"issue":"13","key":"10.1016\/j.bneo.2024.100037_bib42","doi-asserted-by":"crossref","first-page":"9390","DOI":"10.1074\/jbc.275.13.9390","article-title":"Initiation of DNA fragmentation during apoptosis induces phosphorylation of H2AX histone at serine 139","volume":"275","author":"Rogakou","year":"2000","journal-title":"J\u00a0Biol Chem"},{"issue":"5","key":"10.1016\/j.bneo.2024.100037_bib43","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/s41416-020-01199-4","article-title":"SLFN11 informs on standard of care and novel treatments in a wide range of cancer models","volume":"124","author":"Winkler","year":"2021","journal-title":"Br J Cancer"},{"issue":"6","key":"10.1016\/j.bneo.2024.100037_bib44","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1073\/pnas.2015654118","article-title":"SLFN11 promotes CDT1 degradation by CUL4 in response to replicative DNA damage, while its absence leads to synthetic lethality with ATR\/CHK1 inhibitors","volume":"118","author":"Jo","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"10.1016\/j.bneo.2024.100037_bib45","doi-asserted-by":"crossref","first-page":"e441","DOI":"10.1038\/cddis.2012.181","article-title":"Targeting ATR in\u00a0vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation","volume":"3","author":"Fokas","year":"2012","journal-title":"Cell Death Dis"},{"issue":"22","key":"10.1016\/j.bneo.2024.100037_bib46","doi-asserted-by":"crossref","first-page":"9889","DOI":"10.1021\/acs.jmedchem.8b01187","article-title":"Discovery and characterization of AZD6738, a potent inhibitor of ataxia telangiectasia mutated and Rad3 related (ATR) kinase with application as an anticancer agent","volume":"61","author":"Foote","year":"2018","journal-title":"J\u00a0Med Chem"},{"issue":"11","key":"10.1016\/j.bneo.2024.100037_bib47","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/s41594-018-0142-5","article-title":"DNA damage-induced cell death relies on SLFN11-dependent cleavage of distinct type II tRNAs","volume":"25","author":"Li","year":"2018","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.bneo.2024.100037_bib48","article-title":"Mechanisms responsible for the synergistic antileukemic interactions between ATR inhibition and cytarabine in acute myeloid leukemia cells","volume":"7","author":"Ma","year":"2017","journal-title":"Sci Rep"},{"issue":"8","key":"10.1016\/j.bneo.2024.100037_bib49","doi-asserted-by":"crossref","first-page":"11705","DOI":"10.18632\/aging.202865","article-title":"Selenomethionine protects hematopoietic stem\/progenitor cells against cobalt nanoparticles by stimulating antioxidant actions and DNA repair functions","volume":"13","author":"Zhu","year":"2021","journal-title":"Aging (Albany NY)"},{"issue":"1","key":"10.1016\/j.bneo.2024.100037_bib50","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1038\/s41467-017-01834-4","article-title":"The combination of CHK1 inhibitor with G-CSF overrides cytarabine resistance in human acute myeloid leukemia","volume":"8","author":"Di Tullio","year":"2017","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.bneo.2024.100037_bib51","first-page":"27","article-title":"An inflammatory state remodels the immune microenvironment and improves risk stratification in acute myeloid leukemia","volume":"4","author":"Lasry","year":"2023","journal-title":"Nat Can (Ott)"},{"issue":"8","key":"10.1016\/j.bneo.2024.100037_bib52","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1080\/17474086.2017.1346470","article-title":"Immunological effects of hypomethylating agents","volume":"10","author":"Lindblad","year":"2017","journal-title":"Expert Rev Hematol"},{"issue":"5","key":"10.1016\/j.bneo.2024.100037_bib53","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov"},{"issue":"269","key":"10.1016\/j.bneo.2024.100037_bib54","doi-asserted-by":"crossref","first-page":"l1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci Signal"},{"issue":"23","key":"10.1016\/j.bneo.2024.100037_bib55","doi-asserted-by":"crossref","first-page":"3861","DOI":"10.1158\/0008-5472.CAN-23-0816","article-title":"Analysis and visualization of longitudinal genomic and clinical data from the AACR project GENIE biopharma collaborative in cBioPortal","volume":"83","author":"de Bruijn","year":"2023","journal-title":"Cancer Res"},{"issue":"D1","key":"10.1016\/j.bneo.2024.100037_bib56","doi-asserted-by":"crossref","first-page":"D1138","DOI":"10.1093\/nar\/gkad993","article-title":"BloodSpot 3.0: a database of gene and protein expression data in normal and malignant haematopoiesis","volume":"52","author":"G\u00edslason","year":"2023","journal-title":"Nucleic Acids Research"},{"issue":"7728","key":"10.1016\/j.bneo.2024.100037_bib57","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/s41586-018-0623-z","article-title":"Functional genomic landscape of acute myeloid leukaemia","volume":"562","author":"Tyner","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.bneo.2024.100037_bib58","series-title":"Analysis overview for acute myeloid leukemia (primary blood derived cancer - peripheral blood cohort) - 28 January 2016","year":"2016"},{"issue":"8","key":"10.1016\/j.bneo.2024.100037_bib59","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.ccell.2022.07.002","article-title":"Integrative analysis of drug response and clinical outcome in acute myeloid leukemia","volume":"40","author":"Bottomly","year":"2022","journal-title":"Cancer Cell"}],"container-title":["Blood Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950328024000372?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950328024000372?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T02:59:01Z","timestamp":1762657141000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950328024000372"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":57,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S2950328024000372"],"URL":"https:\/\/doi.org\/10.1016\/j.bneo.2024.100037","relation":{},"ISSN":["2950-3280"],"issn-type":[{"value":"2950-3280","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting SLFN11-regulated pathways restores chemotherapy sensitivity in AML","name":"articletitle","label":"Article Title"},{"value":"Blood Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bneo.2024.100037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100037"}}